Skip to main content

Pitfall in cannabinoid analysis—detection of a previously unrecognized interfering compound in human serum

Abstract

In clinical and forensic toxicology, high-performance liquid chromatography/tandem mass spectrometry (LC-MS/MS) is increasingly used since it allows the development of sensitive and fast drug analysis procedures. During development of a LC-MS/MS method for determination of the psychoactive cannabinoid Δ9-tetrahydrocannabinol (THC) and of its two metabolites 11-hydroxy-THC (THCOH) and 11-nor-9-carboxy-THC (THCCOOH) in serum, a previously unrecognized interfering compound was detected. Extending the fast gradient elution program by an isocratic phase leads to sufficient separation of the interfering compound, initially co-eluting with THCCOOH and exhibiting the same fragments. For characterization, product ion scans and precursor ion scans were performed. Samples from cannabis users were analyzed to estimate the abundance of the interfering compound. The mass spectrometric experiments showed that the interfering compound exhibited the same molecular mass as THCCOOH and a similar fragmentation pattern except for relative fragment intensities. This compound was exclusively detectable in authentic samples. Concentrations were in the range of 4.5 to 51 % (median 14.6 %, n = 73) of those of THCCOOH. After further optimization of the gradient, the method was sufficiently selective and sensitive and validation parameters were within acceptance limits. A new compound related to cannabis use was detected in human serum, and data suggest an isomeric structure to THCCOOH. Considering the rather high amounts observed, it was surprising that this compound had not been detected previously. Further studies on its structure and origin are necessary.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3

References

  1. 1.

    European Drug Report 2013: Trends and developments (2013) European Monitoring Center For Drugs And Drug Addiction (EMCDDA), www.emcdda.europa.eu/publications/edr/trends-developments/2013. Accessed 11 Jun 2014

  2. 2.

    United Nations Office on Drugs and Crime (UNODC) (2013) http://www.unodc.org/unodc/secured/wdr/wdr2013/World_Drug_Report_2013.pdf. Accessed 14 Jun 2014

  3. 3.

    Stout PR, Horn CK, Klette KL (2001) Solid-phase extraction and GC-MS analysis of THC-COOH method optimized for a high-throughput forensic drug-testing laboratory. J Anal Toxicol 25:550–554

    CAS  Article  Google Scholar 

  4. 4.

    Steinmeyer S, Bregel D, Warth S, Kraemer T, Moeller MR (2002) Improved and validated method for the determination of Δ9-tetrahydrocannabinol (THC), 11-hydroxy-THC and 11-nor-9-carboxy-THC in serum, and in human liver microsomal preparations using gas chromatography–mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 772:239–248

    CAS  Article  Google Scholar 

  5. 5.

    Gustafson R, Moolchan E, Barnes A, Levine B, Huestis M (2003) Validated method for the simultaneous determination of Δ9-tetrahydrocannabinol (THC), 11-hydroxy-THC and 11-nor-9-carboxy-THC in human plasma using solid phase extraction and gas chromatography–mass spectrometry with positive chemical ionization. J Chromatogr B Analyt Technol Biomed Life Sci 798:145–154

    CAS  Article  Google Scholar 

  6. 6.

    Nadulski T, Sporkert F, Schnelle M, Stadelmann AM, Roser P, Schefter T, Pragst F (2005) Simultaneous and sensitive analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC-MS in plasma after oral application of small doses of THC and cannabis extract. J Anal Toxicol 29:782–789

    CAS  Article  Google Scholar 

  7. 7.

    Toennes SW, Ramaekers JG, Theunissen EL, Moeller MR, Kauert GF (2008) Comparison of cannabinoid pharmacokinetic properties in occasional and heavy users smoking a marijuana or placebo joint. J Anal Toxicol 32:470–477

    CAS  Article  Google Scholar 

  8. 8.

    Kauert GF, Ramaekers JG, Schneider E, Moeller MR, Toennes SW (2007) Pharmacokinetic properties of ∆9-tetrahydrocannabinol in serum and oral fluid. J Anal Toxicol 31:288–293

    CAS  Article  Google Scholar 

  9. 9.

    Maurer HH (2007) Current role of liquid chromatography–mass spectrometry in clinical and forensic toxicology. Anal Bioanal Chem 388:1315–1325

    CAS  Article  Google Scholar 

  10. 10.

    Grebe SK, Singh RJ (2011) LC-MS/MS in the clinical laboratory—where to from here? Clin Biochem Rev 32:5–31

    Google Scholar 

  11. 11.

    Peters FT (2011) Recent advances of liquid chromatography–(tandem) mass spectrometry in clinical and forensic toxicology. Clin Biochem 44:54–65

    CAS  Article  Google Scholar 

  12. 12.

    Schwope DM, Scheidweiler KB, Huestis MA (2011) Direct quantification of cannabinoids and cannabinoid glucuronides in whole blood by liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 401:1273–1283

    CAS  Article  Google Scholar 

  13. 13.

    Teixeira H, Verstraete A, Proença P, Corte-Real F, Monsanto P, Vieira DN (2007) Validated method for the simultaneous determination of Δ9-THC and Δ9-THC-COOH in oral fluid, urine and whole blood using solid-phase extraction and liquid chromatography–mass spectrometry with electrospray ionization. Forensic Sci Int 170:148–155

    CAS  Article  Google Scholar 

  14. 14.

    Simões SS, Ajenjo AC, Dias MJ (2011) Qualitative and quantitative analysis of THC, 11-hydroxy-THC and 11-nor-9-carboxy-THC in whole blood by ultra-performance liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 25:2603–2610

    Google Scholar 

  15. 15.

    Hackett J, Elian A (2012) Solid phase extraction and analysis of THC and metabolites from whole blood using a novel automated procedure using liquid chromatography and tandem mass spectrometry(LC-MS/MS). J Forensic Toxicol Pharmacol 1:1–10

    Google Scholar 

  16. 16.

    Coulter C, Miller E, Crompton K, Moore C (2008) Tetrahydrocannabinol and two of its metabolites in whole blood using liquid chromatography-tandem mass spectrometry. J Anal Toxicol 32:653–658

    CAS  Article  Google Scholar 

  17. 17.

    Jamey C, Szwarc E, Tracqui A, Ludes B (2008) Determination of cannabinoids in whole blood by UPLC-MS-MS. J Anal Toxicol 32:349–354

    CAS  Article  Google Scholar 

  18. 18.

    Desrosiers NA, Himes SK, Scheidweiler KB, Concheiro-Guisan M, Gorelick DA, Huestis MA (2014) Phase I and II cannabinoid disposition in blood and plasma of occasional and frequent smokers following controlled smoked cannabis. Clin Chem 60:631–643

    CAS  Article  Google Scholar 

  19. 19.

    Maralikova B, Weinmann W (2004) Simultaneous determination ofΔ9-tetrahydrocannabinol, 11-hydroxy-Δ9-tetrahydrocannabinol and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in human plasma by high-performance liquid chromatography/tandem mass spectrometry. J Anal Toxicol 39:526–531

    CAS  Google Scholar 

  20. 20.

    Felli M, Martello S, Chiarotti M (2011) LC–MS–MS method for simultaneous determination of THCCOOH and THCCOOH-glucuronide in urine: Application to workplace confirmation tests. Forensic Sci Int 204:67–73

    CAS  Article  Google Scholar 

  21. 21.

    Roth N, Moosmann B, Auwärter V (2013) Development and validation of an LC-MS/MS method for quantification of Δ9-tetrahydrocannabinolic acid A (THCA-A), THC, CBN and CBD in hair. J Mass Spectrom 48:227–233

    CAS  Article  Google Scholar 

  22. 22.

    Salomone A, Gerace E, D’Urso F, Di Corcia D, Vincenti M (2012) Simultaneous analysis of several synthetic cannabinoids, THC, CBD and CBN, in hair by ultra-high performance liquid chromatography tandem mass spectrometry. Method validation and application to real samples. J Mass Spectrom 47:604–610

    CAS  Article  Google Scholar 

  23. 23.

    Peters FT, Hartung M, Herbold M, Schmitt G, Daldrup T, Mußhoff F (2009) Anforderungen an die Validierung von Analysenmethoden. Toxichem Krimtech 76:185–208

    Google Scholar 

  24. 24.

    Peters FT, Drummer OH, Musshoff F (2007) Validation of new methods. Forensic Sci Int 165:216–224

    CAS  Article  Google Scholar 

  25. 25.

    Kolb M, Bahr A, Hippich S, Schulz W (1993) Calculation of detection limit, identification limit and determination limit according to DIN 32645 with the aid of a computer program. Acta Hydrochim Hydrobiol 21:308–311

    CAS  Article  Google Scholar 

  26. 26.

    Matuszewski BK, Constanzer ML, Chavez-Eng CM (2003) Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC − MS/MS. Anal Chem 75:3019–3030

    CAS  Article  Google Scholar 

  27. 27.

    Scheidweiler KB, Schwope DM, Karschner EL, Desrosiers NA, Gorelick DA, Huestis MA (2013) In vitro stability of free and glucuronidated cannabinoids in blood and plasma following controlled smoked cannabis. Clin Chem 59:1108–1117

    CAS  Article  Google Scholar 

  28. 28.

    Grauwiler SB, Scholer A, Drewe J (2007) Development of a LC/MS/MS method for the analysis of cannabinoids in human EDTA-plasma and urine after small doses of Cannabis sativa extracts. J Chromatogr B Analyt Technol Biomed Life Sci 850:515–522

    CAS  Article  Google Scholar 

  29. 29.

    Ferreirós N, Labocha S, Walter C, Lötsch J, Geisslinger G (2013) Simultaneous and sensitive LC–MS/MS determination of tetrahydrocannabinol and metabolites in human plasma. Anal Bioanal Chem 405:1399–1406

    Article  Google Scholar 

  30. 30.

    Bijlsma L, Sancho JV, Hernández F, Niessen WM (2011) Fragmentation pathways of drugs of abuse and their metabolites based on QTOF MS/MS and MSE accurate-mass spectra. J Mass Spectrom 46:865–875

    CAS  Article  Google Scholar 

  31. 31.

    Broecker S, Pragst F (2012) Isomerization of cannabidiol and Δ9-tetrahydrocannabinol during positive electrospray ionization. In-source hydrogen/deuterium exchange experiments by flow injection hybrid quadrupole-time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 26:1407–1414

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Stefan W. Toennes.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Toennes, S.W., Hanisch, S., Pogoda, W. et al. Pitfall in cannabinoid analysis—detection of a previously unrecognized interfering compound in human serum. Anal Bioanal Chem 407, 463–470 (2015). https://doi.org/10.1007/s00216-014-8301-y

Download citation

Keywords

  • Forensic toxicology
  • Drug monitoring
  • Cannabinoids
  • 11-Nor-9-carboxy-delta9-tetrahydrocannabinol
  • Validation